Study of Ongericimab to prevent another stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests a new medicine called Ongericimab to see if it can lower cholesterol and reduce the risk of having another stroke in people who have had a stroke in the last 3 months and have a narrowed artery in the brain or neck.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have had an ischemic stroke (a stroke caused by a blockage) in the last 3 months.
- You must have at least 50% narrowing in a major artery in the brain or neck related to your stroke symptoms.
- Your 'bad' cholesterol (LDL-C) must be at least 70 mg/dL at the screening blood test.
- You must not have had a bleeding stroke at any time in the past.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a cholesterol-lowering medication (PCSK9 inhibitor) can help prevent further strokes in people who have recently had a stroke or mini-stroke due to a narrowed artery in the brain. It is for adults 30 to 80 years old who meet specific health criteria.
This trial tests whether a combination of two or three anti-platelet medicines (like aspirin, clopidogrel, or cilostazol) is safe and works better than one alone for people who had a stroke from a narrowed artery. The goal is to prevent another stroke.
This trial tests a combination of blood thinners to prevent another stroke in people who have a narrowed artery in the brain. It compares standard treatment to a combination of low-dose blood thinners to see if this approach works better to prevent future strokes.
This trial tests whether quickly starting an aggressive cholesterol-lowering treatment after a stroke improves recovery. It is for people who are about to have a procedure to remove a large blood clot from their brain.
This trial tests whether alirocumab, a cholesterol-lowering injection, can stabilize dangerous plaque buildup in neck arteries (carotid arteries) that recently caused a mini-stroke or temporary vision loss. The goal is to reduce your risk of a future stroke.
This trial tests whether placing a stent in a severely narrowed brain artery, along with aggressive medication, can prevent another stroke better than medication alone. It is for people who had a mild stroke within the last 30 days due to a 70-99% blockage in a major brain artery.
Hear when a new Ischemic Cerebral Infarction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.